News Feed Item

MyDx Enters Into An ~$80,000 MyDx360 SaaS Licensing And Services Agreement With Retailer BlackSwan

BlackSwan enters the Delivery Pen and Supplements Markets with I+huntr Brand, Tailored for Performance Athletes, Powered by MyDx360

SAN DIEGO, June 19, 2017 /PRNewswire/ -- MyDx, Inc. (OTCQB: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for cannabis professionals and retail consumers to correlate the chemical profile of cannabis with how it makes them feel and which ailments they report it alleviates, today announced a definitive agreement with BlackSwan, a developer and retailer of custom vaporizers, to provide a community engagement software platform to support its new product development initiatives under the terms of MyDx360.

Licensing Agreement Provides for Branding on Multiple Delivery Mechanisms

As part of the MyDx360 agreement, BlackSwan chose from one of MyDx's base chemical formulations that best alleviated pain and inflammation according to the MyDx community. From there, MyDx software enabled BlackSwan to "boost" that formula by changing various cannabinoid and terpene parameters as well as other natural organic terpenes to come to a final formula uniquely formulated by BlackSwan.

"This uniquely positions MyDx at the center of a revolution in how therapies are developed utilizing chemicals found in cannabis and other naturally occurring plants. The MyDx360 platform makes it incredibly easy for market players to create new high quality tailored formulations that can support their customer's needs.  It also speaks to our ability as a company to execute on our vision of creating a brand centric ecosystem powered by community driven data.  We look forward to supporting BlackSwan and the development of the I+huntr brand personalized for high performance athletes and powered by MyDx360," said Daniel Yazbeck, CEO of MyDx.  

MyDx will continue to work with BlackSwan to support the development of new formulations, which will be manufactured in the form of concentrates via state licensed suppliers, and then delivered via MyDx's hardware, the ECO Smart Pen, and supplements tailored to performance athletes. Once products have been delivered via MyDx's manufacturing partnerships, the MyDx App will provide customer-engagement support to acquire and analyze user feedback. 

BlackSwan to Launch I+huntr Brand for High Performance Athletes

BlackSwan intends to market its unique formula under the I+huntr Brand to athletes seeking alternatives to traditional opioid pain killers, among other ailments – an area the company has significantly researched and thinks will grow into a substantial market, especially as cannabinoid and other natural plant extract therapeutic use becomes more widely accepted. 

"We see this as an opportunity to develop a quality product and reduce the time to market for the Delivery Pen and Supplement markets with targeted formulas we can brand and sell," said BlackSwan CEO, Jeff Lau. "Moreover, we think there's significant opportunity in this space to differentiate, capture market share and truly offer products that might help alleviate specific ailments or side effects as defined by cannabis users and we're excited to be working with the foremost authority on the subject in MyDx."

BlackSwan intends to have its products available for sale by January of 2018 with an initial launch in the State of California, which represents close to 50% of the US cannabis market. The company will offer its products in three distinct organic flavors (Orange Crush, Blueberry and Mint), which will target various levels of recovery based upon cannabis user formulas addressing their anxiety, pain management, recovery, and performance. 

Cannabis Offers the Potential to Curb the Opioid Crisis Among Athletes

Addiction to pain killers is Youth Athletics' dirty little secret as young men and women vie for prestigious college athletic scholarships and eventually elite status as professionals. The abuse is well documented among athletes; however, little to no alternatives have been provided that have the dual potential of alleviating their addictions as well as providing inflammation and pain relief. 

In an article by Sports Illustrated titled "How painkillers are turning young athletes into heroin addicts", SI covered the tragic story of Roman Montano, a high school baseball Phenom who was destined to be a star and, at one time, started over current Phillies Ace, Ken Giles. Unfortunately, that story would never came true. A foot injury would lead to an OxyContin addiction that would eventually transform him into a heroin addiction. That heroin addiction would end that young man's life at a tender age of 22. 

Unfortunately, we'll never know what might have been had Roman remained healthy, and it's a story that hasn't been lost on BlackSwan CEO Jeff Lau. 

"This is a topic that many people aren't talking about because it's a bit taboo, there's big money involved and there's immense pressure to perform when injured," said BlackSwan CEO, Jeff Lau. "Fortunately, the chemicals in cannabis have shown tremendous promise in its ability to alleviate pain and inflammation in much of the same way as opioids, but without the propensity for addiction, and with the potential for additional health benefits, which are still undergoing studies."

The reality is that since cannabis is still a Scheduled I drug federally, many people who would otherwise have alternatives to opioids can't get them. Moreover, if they decided to use cannabis as an alternative, then they could potentially violate substance abuse policies that currently exist in all levels of athletics and that could have severe consequences, financial or otherwise. 

The good news is that formulating cannabis with ingredients that have healing factors without the "high" associated with cannabis (namely CBD and various Terpenes) is gaining wider-acceptance and could potentially one day be the drawing line that many athletes have hoped for. This is exactly the area BlackSwan intends to focus on with the help of MyDx.

CBD and Terpene Formulations Have Demonstrated Anti-Inflammation Properties

CBD has been reported by various publications and research reports to be a cannabinoid known for its extensive therapeutic value. It is a powerful anti-epileptic, anti-depressant, anti-inflammatory, anti-nauseate, sleep aid, muscle relaxant, sedative and anti-proliferative. Some people call it the "Miracle Drug." What makes it popular among users is its non-psychotropic properties, meaning it does not give you the "high" that you feel when you consume THC. As a result, it can also be administered at relatively high doses without any known undesired psychological side effects.

Terpenes are naturally occurring compounds that give plants and flowers their unique smell. In cannabis plants, terpenes originate from the same glands that produce THC, CBD and other cannabinoids and assist the effects of cannabinoids by also interacting with endocannabinoid system in people, otherwise known as the "Entourage Effect." Terpenes with anti-inflammatory and pain reducing properties include Caryophyllene, Linalool, and Pinene, to name a few. 

To learn more about the cannabinoids, terpenes, the entourage effect, and the science of how they all interact to impact our physiology, please refer to Part 3: Cannabis 2.0 on page 17 of the MyDx White Paper.

About MyDx, Inc.

MyDx, Inc. (OTCQB: MYDX) is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust & Verify® what they put into their minds and bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user's hand. The multi-use MyDx analyzer leverages over a decade of established chemical detection technology to measure chemicals of interest. The Company owns a substantial and growing intellectual property portfolio of patents covering its technology. The MyDx AquaDx®, OrganaDx(TM) and CannaDx(TM) sensors are now commercialized, and the AeroDx® application is next in line. All sensors will be compatible with a MyDx App that empowers consumers to live a healthier life by revealing the chemical composition of what they eat, drink and inhale. For more information, please visit www.cdxlife.com.

Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at http://ir.cdxlife.com/all-sec-filings or www.sec.gov.

Investor Contact:
MyDx Shareholder Communications
800.814.4550 ext. 4
[email protected]


To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mydx-enters-into-an-80000-mydx360-saas-licensing-and-services-agreement-with-retailer-blackswan-300475524.html


More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Evatronix will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Evatronix SA offers comprehensive solutions in the design and implementation of electronic systems, in CAD / CAM deployment, and also is a designer and manufacturer of advanced 3D scanners for professional applications.
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to close th...
"Digital transformation - what we knew about it in the past has been redefined. Automation is going to play such a huge role in that because the culture, the technology, and the business operations are being shifted now," stated Brian Boeggeman, VP of Alliances & Partnerships at Ayehu, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
The past few years have brought a sea change in the way applications are architected, developed, and consumed—increasing both the complexity of testing and the business impact of software failures. How can software testing professionals keep pace with modern application delivery, given the trends that impact both architectures (cloud, microservices, and APIs) and processes (DevOps, agile, and continuous delivery)? This is where continuous testing comes in. D
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"WineSOFT is a software company making proxy server software, which is widely used in the telecommunication industry or the content delivery networks or e-commerce," explained Jonathan Ahn, COO of WineSOFT, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...
There is a huge demand for responsive, real-time mobile and web experiences, but current architectural patterns do not easily accommodate applications that respond to events in real time. Common solutions using message queues or HTTP long-polling quickly lead to resiliency, scalability and development velocity challenges. In his session at 21st Cloud Expo, Ryland Degnan, a Senior Software Engineer on the Netflix Edge Platform team, will discuss how by leveraging a reactive stream-based protocol,...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
Sanjeev Sharma Joins June 5-7, 2018 @DevOpsSummit at @Cloud Expo New York Faculty. Sanjeev Sharma is an internationally known DevOps and Cloud Transformation thought leader, technology executive, and author. Sanjeev's industry experience includes tenures as CTO, Technical Sales leader, and Cloud Architect leader. As an IBM Distinguished Engineer, Sanjeev is recognized at the highest levels of IBM's core of technical leaders.
Product connectivity goes hand and hand these days with increased use of personal data. New IoT devices are becoming more personalized than ever before. In his session at 22nd Cloud Expo | DXWorld Expo, Nicolas Fierro, CEO of MIMIR Blockchain Solutions, will discuss how in order to protect your data and privacy, IoT applications need to embrace Blockchain technology for a new level of product security never before seen - or needed.
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...